Pharma Stock Skyrockets to Record Peaks: Why Investors Are Calling It a ‘Strong Buy’ and What It Means for Your Portfolio
Insmed (INSM) is capturing serious investor attention as it surges to new heights, hitting a fresh 52-week high of $130.13 on August 18. What makes this biopharmaceutical stock stand out isn’t just its price action—though … Read more